Recombinant Human IGF2 Protein，His

Insulin-like growth factor 2 (IGF2) is a critical peptide hormone involved in growth and development, particularly during fetal and postnatal stages. Research on IGF2 recombinant proteins has gained significant attention due to their potential therapeutic applications in treating growth disorders and metabolic diseases. IGF2 is known to play key roles in cellular proliferation, differentiation, and apoptosis, making it a vital factor in various physiological processes. Its dysregulation is associated with numerous conditions, including cancer and other growth-related disorders. The ability to produce IGF2 as a recombinant protein allows for detailed investigations into its biological functions and therapeutic applications. Furthermore, recombinant IGF2 can be engineered to enhance its stability and activity, providing insights into its mechanism of action and interactions with IGF receptors. As interest in hormone-based treatments increases, understanding the structure-function relationship of IGF2 and its signaling pathways is crucial for developing effective therapies. Advanced biotechnological methods enable the large-scale production of IGF2, contributing to research on its role in human health and disease management. Consequently, the exploration of IGF2 recombinant proteins offers promising avenues for therapeutic innovation, particularly in regenerative medicine and metabolic disease interventions.